SALT LAKE CITY, Feb. 13, 2013 /PRNewswire/ -- Remedy Informatics today announced that it is the first vendor authorized by the Center for International Blood & Marrow Transplant Research (CIBMTR) to submit all CIBMTR forms currently supported by CIBMTR's AGNIS system. This achievement represents a significant milestone in Remedy's efforts to help its clients improve clinical outcomes for BMT patients by giving BMT centers the tools necessary to easily access and analyze clinical data.
Remedy officially launched its "Live In Five" program, committing to deploy a fully functional instance of ComprehensiveBMT throughout a BMT center in only five business days.
"The purpose of Remedy Informatics' clinical products is to support our clients' efforts to improve patient care by providing software solutions that will accelerate both clinical research and quality improvement initiatives — that is the central focus of ComprehensiveBMT," said Jonathan Dewey, MD, director of clinical products at Remedy Informatics. "Furthermore, our new five-day deployment strategy has already enabled our clients to derive benefits almost immediately. This is unlike traditional institution-wide software installations and deployments that can take months or years, and are often mired in red tape along the way."Dr. Douglas Rizzo, CIBMTR's Associate Scientific Director for Data Operations and CIBMTR Executive Committee member, corroborated Remedy's claim. "Remedy Informatics has demonstrated the ability to submit data for all CIBMTR forms currently supported by the AGNIS system, and is now authorized by the CIBMTR for this activity in AGNIS," said Rizzo. "Expanded forms submission by Remedy represents one of several examples of increasing utilization of the AGNIS application to automate data exchange with the CIBMTR for the benefit of transplant centers and researchers." In addition, Remedy Informatics offers a version of its Investigate™ product, specially designed for Cell Therapy labs. InvestigateCT™ is an integrated research management system designed to provide BMT and cell therapy laboratories an end-to-end service line production and research system. InvestigateCT operationalizes cell products biobanking, cell processing laboratory protocols and research study management, all on the same Mosaic™ Platform as ComprehensiveBMT. Which means that both products are automatically able to share data, annotations, results and gain a composite view of each patient, subject or donor.